Filing Details
- Accession Number:
- 0001179110-12-006384
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-04 13:44:19
- Reporting Period:
- 2012-04-02
- Filing Date:
- 2012-04-04
- Accepted Time:
- 2012-04-04 13:44:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1334682 | H Gregg Alton | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, Corp & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-04-02 | 4,000 | $17.50 | 47,057 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-04-02 | 5,000 | $48.53 | 42,057 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-04-02 | 4,000 | $0.00 | 4,000 | $17.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
31,875 | 2013-07-29 | No | 4 | M | Direct |
Footnotes
- Pursuant to a Rule 105b-1 trading plan established by Mr. Alton on February 7, 2012.
- The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- Sale prices reported for the transactions reported here range from $47.90 to $48.72. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.